JPRN-UMIN000002573
Completed
Phase 4
Multicenter Prospective Randomized Study of First-choice Guidewires in Percutaneous Coronary Intervention for Chronic Total Occlusion - G-FORCE
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Patients undergoing Percutaneous Coronary Intervention (PCI) for chronic total occlusion (CTO)
- Sponsor
- Tokai University
- Enrollment
- 290
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients for whom PCI is not indicated Patients with the same CTO previously treated with PCI without success Patients with restenosis or in\-stent restenosis Patients with a venous or arterial graft Patients under 21 years old Women of child\-bearing potential Patients who do not provide informed consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
First-line treatment for different subgroups of lymphomasIndolent Non-Hodgkin Lymphomas, in particular follicular lymphomas, as well as marginal zone lymphomas, immunocytomas (Waldenström’s macroglobulinaemia) and mantle cell lymphomasTherapeutic area: Diseases [C] - Cancer [C04]EUCTR2008-005859-16-DEStiL Forschungs-GmbH874
Completed
Not Applicable
A clinical study of the Triathlon knee prostheses using individualized patient matched operation toolsISRCTN44765636Stryker SA (Switzerland)144
Recruiting
Not Applicable
Multicenter and Prospective Clinical Study for the Development of Multi-Omics-Based Biomarkers in Acute Myeloid LeukemiaDiseases of the blood and blood -forming organs and certain disorders involving the immune mechanismKCT0004825Chonnam National University Hospital Hwasun Hospital620
Recruiting
Not Applicable
A Multicenter Prospective Randomized Study of Fully Covered Metallic Stent versus Tube Stent in Patients with Borderline Resectable Pancreatic CarcinomaPancreatic carcinomaJPRN-UMIN000024832agoya University40
Completed
Phase 4
*A prospective randomized multicenter study to demonstrate the superiority of the Barricaid® to discectomy for primary lumbar disc herniation*: Extended Follow-Up of the Barricaid® Annular Closure Device (ACD) Randomized Control Trial (RCT) Postmarket Cohort for Lumbar Disc Herniation and Interaction with Other Risk Factorslumbar disc herniationsciatica100432371004154310009720NL-OMON55882Intrinsic Therapeutics, GmbH66